Credit Suisse’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-502,861
| Closed | -$68.6M | – | 4543 |
|
|
2020
Q3 | $68.6M | Buy |
502,861
+4,928
| +1% | +$524K | 0.04% | 485 |
|
|
2020
Q2 | $48.1M | Buy |
497,933
+95,139
| +24% | +$7.94M | 0.03% | 553 |
|
|
2020
Q1 | $18.9M | Sell |
402,794
-44,666
| -10% | -$2.86M | 0.02% | 874 |
|
|
2019
Q4 | $32.6M | Buy |
447,460
+8,923
| +2% | +$541K | 0.02% | 763 |
|
|
2019
Q3 | $22.9M | Buy |
438,537
+11,815
| +3% | +$628K | 0.02% | 830 |
|
|
2019
Q2 | $21.4M | Buy |
426,722
+47,633
| +13% | +$2.32M | 0.02% | 890 |
|
|
2019
Q1 | $19.7M | Sell |
379,089
-21,080
| -5% | -$971K | 0.02% | 874 |
|
|
2018
Q4 | $19.6M | Buy |
400,169
+73,577
| +23% | +$4.05M | 0.02% | 802 |
|
|
2018
Q3 | $21.3M | Buy |
326,592
+8,343
| +3% | +$491K | 0.02% | 840 |
|
|
2018
Q2 | $15.8M | Sell |
318,249
-96,665
| -23% | -$4.68M | 0.02% | 967 |
|
|
2018
Q1 | $20.2M | Buy |
414,914
+160,613
| +63% | +$8.35M | 0.02% | 847 |
|
|
2017
Q4 | $10.7M | Buy |
254,301
+192,301
| +310% | +$7.41M | 0.01% | 1243 |
|
|
2017
Q3 | $2.66M | Buy |
+62,000
| New | +$1.98M | ﹤0.01% | 2297 |
|
|
2017
Q1 | – | Sell |
-20,093
| Closed | -$260K | – | 4177 |
|
|
2016
Q4 | $260K | Buy |
20,093
+2,613
| +15% | +$40.2K | ﹤0.01% | 3718 |
|
|
2016
Q3 | $285K | Buy |
+17,480
| New | +$316K | ﹤0.01% | 3678 |
|
Credit Suisse's MYOK Position: Q4 2020 in Review
Credit Suisse sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 502,861 shares — an estimated $68.6M sold.
Credit Suisse first reported a position in MYOK in Q3 2016 and held it in 15 quarters. The position peaked at $68.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Credit Suisse reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Credit Suisse sold 502,861 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $68.6M.
- Credit Suisse first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 15 quarters.
- Credit Suisse's MyoKardia, Inc. Common Stock position peaked at $68.6M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.